Paracetamol metabolism in patients with ulcerative colitis

British Journal of Clinical Pharmacology

Volumn 46, Issue 5, 1998, Pages 513-516

  Haderslev, K V ^a,c   Sonne, J ^a   Poulsen, H E ^b   Loft, S ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Paracetamol; Sulphation; Ulcerative colitis

Indexed keywords

DRUG METABOLITE; PARACETAMOL; PARACETAMOL GLUCURONIDE; PARACETAMOL SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON MUCOSA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLIC CLEARANCE RATE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SULFATION; ULCERATIVE COLITIS; VENOUS BLOOD;

ACETAMINOPHEN; COLITIS, ULCERATIVE; FEMALE; GLUCURONATES; GLUTATHIONE; HUMANS; MALE; METABOLIC CLEARANCE RATE; PHENOLS; SULFATES;

EID: 0031762542     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00808.x     Document Type: Article

References (17)

1. MacFarlane GT, Allison C. Utilisation of protein by human gut bacteria. FEMS Microbiol Ecol 1986; 38: 19-24.
2. Boutwell RK, Bosch DK. The tumor-promoting action of phenol and related compounds for mouse skin. Cancer Res 1959; 19: 413-427.
3. Bryan GT. The role of urinary tryptophan metabolites in the etiology of bladder cancer. Am J Clin Nutr 1971; 24: 841-847.
4. Bingham SA. Meat, starch, and nonstarch polysaccharides and large bowel cancer. Am J Clin Nutr 1988; 48 (Suppl): 762-767.
5. Ramakrishna BS, Roberts Thomson IC, Pannall FR, Roediger WE. Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis [see comments]. Gut 1991; 32: 46-49.
6. Cummings AJ, King ML, Martin BK. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol 1967; 29: 150-157.
7. Rampton DS, McNeil NI, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983; 24: 187-189.
8. Poulsen HE, Lerche A, Pedersen NT. Phenobarbital induction does not potentiate hepatotoxicity but accelerates liver cell necrosis from acetaminophen overdose in the rat. Pharmacology 1985; 30: 100-108.
9. Critchley JA, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF. Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986; 22: 649-657.
10. Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982; 7: 93-107.
11. Steventon GB, Heafield MT, Waring RH, Williams AC, Sturman S, Green M. Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica 1990; 20: 117-122.
12. Bradley H, Waring RH, Emery P, Arthur V. Metabolism of low-dose paracetamol in patients with rheumatoid arthritis. Xenobiotica 1991; 21: 689-693.
13. Kamali F, Thomas SH, Ferner RE. Paracetamol elimination in patients with non-insulin dependent diabetes mellitus. Br J Clin Pharmacol 1993; 35: 58-61.
14. Mucklow JC, Fraser HS, Bulpitt CJ, Kahn C, Mould G, Dollery CT. Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol 1980; 10: 67-74.
15. Divoll M, Abernethy DR, Ameer B, Greenblatt DJ. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther 1982; 31: 151-156.
16. Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976; 19: 284-294.
17. Miners JO, Penhall R, Robson RA, Birkett DJ. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol 1988; 35: 157-160.